Begin main content

Secukinumab

Last Updated: January 21, 2016
Result type: Reports
Project Number: SR0475-000
Product Line: Common Drug Review

Generic Name: Secukinumab

Brand Name: Cosentyx

Manufacturer: Novartis Pharmaceuticals Canada Inc.

Indications: Ankylosing spondylitis

Submission Type: New

Project Status: Active

Date Recommendation Issued: August 23, 2016

Recommendation Type: Reimburse with clinical criteria and/or conditions